2939 |
Ad Hoc vs. Staged PCI for Multivessel Disease: Safety First, Choose Wisely! |
Stephen G. Ellis |
Apr. 21. 16 |
2938 |
How to Close Post MI Ventricular Septal Defects |
Yun-Ching Fu |
Apr. 21. 16 |
2937 |
FFR and Clinical Outcomes: Evidence Has Never Been Stronger |
Seung-Jung Park |
Apr. 21. 16 |
2936 |
FFR in the Bifurcation Treatment |
Farhat Fouladvand |
Apr. 21. 16 |
2935 |
Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect |
Bon-Kwon Koo |
Apr. 21. 16 |
2934 |
VSD Closure in 2016; An Overview |
Do Nguyen Tin |
Apr. 21. 16 |
2933 |
Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice |
William F. Fearon |
Apr. 21. 16 |
2932 |
Management of Stable Coronary Heart Disease with Objective Ischemia: COURAGE, FAME2 and Recent Meta-Analysis |
Gregg W. Stone |
Apr. 21. 16 |
2931 |
[TCTAP A-069] Guidewire Assisted Device Placement in Large ASD with Aortic Rim Deficiency - An Easy and Simple Method |
Kenji Suda |
Apr. 21. 16 |
2930 |
SYNTAX-1, SYNTAX-II, SYNTAX-III: From Invasive to Non-Invasive Assessment of Coronary Stenosis |
Patrick W. Serruys |
Apr. 21. 16 |